Primary Job Title Member of the Board of Directors Primary Organization 
7TM Pharma
Location Copenhagen, Hovedstaden, Denmark Regions European Union (EU), Nordic Countries, Scandinavia Gender Male
Investor Type
LinkedIn View on LinkedIn
Soren Carlsen has been employed with the Novo Group since 1979. He was appointed Vice President of Biotechnology in 1986, and in 1991-92 he established Novo Nordisk Biotech, Inc, in California, USA.
From 1994-2000 Soren Carlsen worked at Novo Nordisk Enzyme Business (today Novozymes) as Corporate Vice President and Chief Scientific Officer.
In 2000 he moved to his present position at Novo A/S as Managing Partner to establish Novo’s Life Science Investment activities. In 2007 Soren Carlsen started Novo Seeds for early stage investments
Soren Carlsen holds a MSc in chemical engineering from The Technical University of Denmark and a MSc in brewing technology from the Scandinavian School of brewing.
Soren Carlsen is a member of the Board of Directors of PTC Therapeutics, Santaris Pharma, 7TM Pharma A/S and DTU Symbion Innovation. Soren Carlsen was a co-founder of “Dansk Biotek” – the association of Danish biotech Industries – in 1986 and has been chairman since 1994.
He was awarded The Danish Chemistry price in 1988.
